BTL Super Inductive System

High-intensity magnetic field therapy for pain reduction, neuromuscular stimulation and functional rehabilitation

The BTL Super Inductive System is a non-invasive therapeutic procedure that works with a focused, high-intensity electromagnetic field. Unlike conventional low-intensity magnetic field therapies, the system is not aimed merely at a general “magnetic field effect”, but at the targeted stimulation of nerves, muscles and deep musculoskeletal structures. According to the manufacturer, depending on the device version, the system generates an electromagnetic field of up to 2.5–3 Tesla, operates within a frequency range of up to 150 Hz and can reach tissue depths of up to 10 cm (BTL, BTL Australia).

At RECURIO, high-intensity magnetic field therapy is not used as an isolated standard treatment, but is embedded in physician-led diagnostics and a structured therapy programme. The aim is to reduce pain, improve mobility, support neuromuscular function and specifically complement rehabilitation in selected orthopaedic, sports medicine and functional conditions.

What is the BTL Super Inductive System?

The BTL Super Inductive System, often also referred to as SIS therapy, generates a strong electromagnetic field through an externally positioned applicator. Treatment is performed without skin contact, usually through clothing, and is adapted to the condition and tolerance of the patient by adjusting intensity, frequency, treatment duration and applicator position. Depending on the setting, patients typically feel tingling, rhythmic muscle activation or clear but controlled muscle contractions (BTL).

The method differs from conventional electrotherapy in that no electrodes need to be attached to the skin. The electromagnetic field can reach deeper neuromuscular tissue and trigger electrical activity there without directly irritating the skin. According to the manufacturer, the system can penetrate up to 10 cm, allowing deeper muscles, joint regions and pain-relevant structures to be addressed (BTL, BTL Australia).

How does high-intensity magnetic field therapy work?

The effect of the BTL Super Inductive System is based on electromagnetic induction. The alternating magnetic field can trigger electrical activity in the tissue and thereby influence nerves and muscles. Depending on frequency, intensity and target region, different therapeutic effects may be pursued: pain relief, muscle relaxation, muscle activation, joint mobilisation and support of functional rehabilitation (BTL).

Pain modulation

In pain therapy, the system is used to influence neuronal excitability and pain processing. BTL describes frequency-dependent approaches based on established neurophysiological pain models, including gate control mechanisms and endogenous pain inhibition (BTL SIS Brochure). Clinically, this means that the treatment is intended not merely to “warm” or relax locally, but to contribute to pain relief through neuromuscular and neurophysiological stimulation.

Muscle activation and muscle relaxation

Through the depolarisation of motor nerves, the electromagnetic field can trigger visible muscle contractions. In selected patients, this can be used to activate muscles, reduce muscular inhibition after pain or immobilisation and prepare therapeutic exercises. In other settings, treatment may be aimed at muscle relaxation and tone regulation (BTL).

Joint mobilisation and functional rehabilitation

In cases of restricted mobility, repeated and controlled activation of the muscles surrounding a joint can support mobilisation. BTL describes this effect as a form of electromagnetically induced muscle work that can complement, but not replace, manual mobilisation (BTL). At RECURIO, the method is therefore always considered within the context of an overall plan: diagnostics, indication, active therapy, load management and progress monitoring.

For which conditions may the procedure be useful?

At RECURIO, the BTL Super Inductive System may be considered for selected musculoskeletal and neuromuscular conditions. Whether the treatment is appropriate depends not only on the diagnosis, but also on the underlying cause, tissue status, irritability, functional limitation, previous treatments and therapeutic goal.

Possible areas of application include:

• Acute and chronic musculoskeletal pain: for example back, neck, shoulder, knee or hip pain, once a medical assessment has been carried out.

• Back pain and functional disorders of the spine: for example muscular guarding, restricted mobility or chronic pain processing.

• Tendinopathies and overuse conditions: for example shoulder, patellar tendon, Achilles tendon or elbow complaints as a complement to load management and active rehabilitation.

• Joint blockages and movement restrictions: when muscle activation or relaxation can support mobilisation.

• Muscle weakness and neuromuscular inhibition: particularly after pain, immobilisation or as part of a rehabilitation plan.

• Selected bone healing processes: for example in medically assessed fracture healing or delayed bone healing, although the clinical evidence in this area must be interpreted cautiously.

• Neurological rehabilitation: for example in spastic tone changes, provided there is a clear medical indication.

Clinical evidence: what is well supported and what is not yet?

The clinical evidence for the BTL Super Inductive System is growing, but it is not equally strong for all indications. For some areas of application, there are smaller controlled studies, observational studies and case reports. For other indications, data remain limited or come from multimodal treatment concepts in which the isolated contribution of magnetic field therapy is difficult to determine.

A randomised controlled pilot study on rehabilitation after severe COVID-19 pneumonia compared high-intensity electromagnetic field therapy with the BTL-6000 Super Inductive System plus breathing exercises against low-intensity magnetic field therapy plus breathing exercises. The study included 40 patients and showed stronger improvements in spirometry parameters in the SIS group; no adverse effects or treatment discontinuations were reported (Silantyeva 2020).

A study on post-stroke spasticity examined 60 patients with spastic upper limbs after stroke and found improvements in spasticity and function after SIS stimulation, comparing different application protocols (Ciortea et al. 2022). These data are interesting for neurological rehabilitation questions, but cannot be transferred one-to-one to orthopaedic pain.

For musculoskeletal pain, a randomised cohort control study compared standard therapy with standard therapy plus Super Inductive Magnetic System and reported significant differences in favour of the additional SIS therapy (Mahmudov 2024). However, the authors themselves note that further research is needed to better assess accuracy, comparability and effectiveness in relation to other treatment methods (Mahmudov 2024).

A prospective observational study of 56 patients with carpal tunnel syndrome showed significant improvements in pain, paraesthesia and daily function after two weeks of rehabilitation with three SIS sessions per week plus additional physical therapies (Jimbu et al. 2023). The strength of the evidence is limited because patients received several therapies simultaneously, no long-term data were available and the study was not placebo-controlled (Jimbu et al. 2023).

For bone healing processes, there are case reports, for example on the combination of extracorporeal shockwave therapy and the Super Inductive System in delayed tibial fracture healing (Kouloulas 2018). Such reports can support biological and clinical plausibility, but they do not replace large randomised studies.

The serious and balanced assessment is therefore: the BTL Super Inductive System is a promising, non-invasive adjunct in pain therapy and rehabilitation. However, it should not be understood as an isolated “miracle therapy”, but as one component of a medically justified treatment plan.

BTL Super Inductive System vs. conventional magnetic field therapy

Treatment process at RECURIO

Treatment begins with a medical assessment. This includes evaluating the condition, identifying which structures are affected, checking for warning signs or contraindications and defining a realistic therapeutic goal: pain reduction, improved mobility, muscle activation, relief, rehabilitation progress or combination with other methods.

During treatment, the applicator is positioned over the target area. Direct skin contact is not required. Depending on indication and protocol, treatment usually lasts from a few minutes to around 20 minutes. The intensity is set so that the stimulation is effective but well tolerated. Depending on the goal, patients may feel tingling, pulsing sensations or muscle contractions.

The number of sessions is determined individually. Manufacturer information often refers to treatment series of around 5 to 10 sessions, with duration and frequency adapted according to the condition, therapy plan and clinical progress (BTL, BTL Australia). At RECURIO, treatment is often combined with active therapy, load management, shockwave therapy, high-power laser, medical training therapy or other methods when medically appropriate.

Safety and contraindications

The treatment is non-invasive and is generally described as well tolerated in the available studies. In the randomised pilot study on post-COVID rehabilitation, no adverse effects, complications or treatment discontinuations were reported (Silantyeva 2020). In the observational study on carpal tunnel syndrome, patients with certain risk profiles were excluded, including pacemakers, mechanical implants, coagulation disorders, active infections, pregnancy, oncological disease and respiratory insufficiency (Jimbu et al. 2023).

A medical assessment is particularly required in cases of:

• Pacemakers, defibrillators, neurostimulators or other active electronic implants

• Pregnancy

• Unclear or active tumour disease in the treatment area

• Acute infections, fever or open skin lesions in the treatment area

• Unexplained neurological symptoms

• Relevant coagulation disorders or increased bleeding risk

• Metallic implants or foreign materials whose safety must be assessed individually

This list does not replace an individual medical assessment. Whether high-intensity magnetic field therapy is suitable in a specific case is decided by the medical team based on medical history, findings and therapeutic goal.

Why RECURIO for high-intensity magnetic field therapy?

At RECURIO, the BTL Super Inductive System is not used as a generic magnetic field treatment. The method is part of a structured medical approach: first understanding what is causing the symptoms, then deciding whether neuromuscular, pain-modulating or rehabilitative stimulation is appropriate, and finally monitoring progress and response.

Especially in complex pain, persistent functional disorders, tendinopathies, back problems or rehabilitation processes, simply applying a device is rarely enough. What matters is the correct indication, the appropriate combination of methods and a clear plan for reducing pain, building resilience and improving everyday function.

If you would like to know whether high-intensity magnetic field therapy with the BTL Super Inductive System is suitable for your condition, arrange a medical consultation at RECURIO. Together, we will assess whether the method makes sense as part of an individual therapy programme and which next steps are medically justified for your situation.